Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2015 Genitourinary Cancers Symposium /
Expert commentary on emerging research in genitourinary cancer

26th - 28th Feb 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.02.15
Views: 5623

Dr Chris Parker - The Royal Marsden Hospital, London, UK

Dr Parker talks to ecancertv at ASCO GU 2015 about some of the most interesting and provocative research in genitourinary cancers emerging from the symposium.

He addresses the ASCENDE-RT trial, comparing external beam therapy vs. brachyotherapy, discusses the update of the GETUG-15 trial, and touches on the controversial and exciting results of the MCR-PR07 trial on statins. 

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company). 

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation